The latest research news and events from the University of East London
UEL investigations into the neuro-psychological effects of the drug Ecstasy have been used to inform legal debate on the drug’s re-classification and warn recreational users of the risks involved, particularly to a baby’s development when taken in pregnancy.
MDMA, more commonly known as Ecstasy, is often the subject of intense public and political debate, particularly with regards to its harmful effects and legal classification.
Researchers from UEL’s Drugs and Addictive Behaviours Research Group (DAB) and the UEL Institute for Research in Child Development (IRCD) have contributed to this debate by providing key information about the neuro-psychological risks of MDMA use. Their research has influenced UK and US government debate about the drug’s legalisation and enabled government, medical professionals and specialist information websites to provide more accurate advice to pregnant women and recreational drug users.
Read more on the UEL Research website.